ZYRTEC® provides consistent, long-term relief for patients with seasonal and perennial allergic rhinitis*1

  • ZYRTEC® provides consistent relief from perennial allergic rhinitis (PAR) over
    a 4 to 8 week treatment period.*1
Percent reduction from baseline in TSSC — PAR
  • ZYRTEC® provides consistent relief from seasonal allergic rhinitis (SAR) over
    a 2 to 4 week treatment period.*1
Percent reduction from baseline in TSSC — SAR
 

*All studies are multicenter, randomized, placebo-controlled, double-blind, minimum 100 participants, and of adequate minimum duration (SAR: 2 weeks or PAR: 4 weeks). Total symptom severity score measured by patient.

Reference:

1. Data on file, McNEIL-PPC, Inc.